TN5227 |
(+/-)-Vestitol
|
56701-24-7
|
98%
|
|
Vestitol has antioxidation, anti-inflammatory and antimicrobial activities, it can strongly act in a low dose and concentration and have a promising potential to...
|
TP2141L |
Balixafortide
|
1051366-32-5
|
98%
|
|
Balixafortide (POL6326) is a potent, selective, well-tolerated peptidic CXCR4 antagonist with an IC50 < 10 nM and it is also a potent hematopoietic stem and prog...
|
T11140 |
E6130
|
1427058-33-0
|
98%
|
|
E6130 may be effective in the treatment of inflammatory bowel disease and is a highly selective CX3CR1 regulator for oral administration.
|
T19386 |
ITIC
|
1664293-06-4
|
98%
|
|
ITIC has a superior thermal stability and undergoes a glass-crystal transition considerably below its high Tg of 180 °C. ITIC, non-fullerene acceptor, is an inda...
|
T10905 |
CXCR2-IN-1
|
1873376-49-8
|
98%
|
|
CXCR2-IN-1 has a pIC50 of 9.3 and is a CXCR2 antagonist of the central nervous system penetration agent.
|
T14665 |
Motixafortide
|
664334-36-5
|
98%
|
|
Motixafortide (BKT140 4-fluorobenzoyl) is an antagonist of CXCR4 (IC50: 1 nM).
|
T10635 |
Burixafor hydrobromide
|
1191450-19-7
|
98%
|
|
Burixafor hydrobromide (TG-0054 hydrobromide) is an orally bioavailable and potent CXCR4 antagonist and an anti-angiogenic drug that is of potential value in tre...
|
TP2141 |
Balixafortide TFA (1051366-32-5 free base)
|
TP2141
|
98%
|
|
Balixafortide TFA (POL6326 TFA) is a selective, well-tolerated peptidic CXCR4 antagonist (IC50 < 10 nM). It shows 1000-fold selective for CXCR4 than a large pane...
|
T19385 |
ITIC-4F
|
2097998-59-7
|
98%
|
|
ITIC-4F has broad applicability in high-efficiency binary and ternary single-junction as well as tandem polymer solar cells (PSCs).ITIC-4F is an indacenodithieno...
|
T16933 |
SRT3190
|
1204707-73-2
|
98%
|
|
SRT3190 is an antagonist of CXCR2.
|
T12269L |
NUCC-390 dihydrochloride (1060524-97-1 free base)
|
T12269L
|
98%
|
|
NUCC-390 dihydrochloride is selective agonist of small-molecule CXCR4 receptor.
|
T6764 |
ATI-2341
|
1337878-62-2
|
98%
|
|
ATI-2341, pepducin targeting the C-X-C chemokine receptor type 4 (CXCR4), is an allosteric agonist activating the inhibitory heterotrimeric G protein (Gi) to pro...
|
T16864 |
SCH 563705
|
473728-58-4
|
98%
|
|
SCH 563705 is an effective and orally available CXCR2 and CXCR1 antagonist (IC50s: 1.3 nM, 7.3 nM and Kis of 1 and 3 nM, respectively).
|
T9721 |
ML339
|
2579689-83-9
|
98%
|
|
ML339 a selective inhibitor of CXCR6(IC50 = 140 nM) with no response when screened against CXCR5 and CXCR4.
|
T16850 |
SB-265610
|
211096-49-0
|
98%
|
|
SB-265610 is a nonpeptide and allosteric CXCR2 antagonist. SB-265610 blocks rat cytokine-induced neutrophil chemoattractant-1 (CINC-1)-induced calcium mobilizati...
|
TP2051L |
CTCE 9908 acetate
|
|
98%
|
|
CTCE 9908 acetate is an antagonist of CXCR4 and inhibits migration in CXCR4-expressing ovarian cancer cells.
|
TQ0174 |
Mavorixafor
|
558447-26-0
|
98%
|
|
Mavorixafor is an effective and selective antagonist of CXCR4, with an IC50 value of 13 nM against CXCR4 125I-SDF binding. Mavorixafor inhibits the replication o...
|
TP1364L |
ALX 40-4C acetate
|
TP1364L
|
98%
|
|
ALX 40-4C acetate is a CXCR4 inhibitor of the chemokine receptor (Ki = 1 μM) and suppresses the replication of X4 strains of HIV-1. ALX 40-4C acetate is an antag...
|
T12269 |
NUCC-390
|
1060524-97-1
|
98%
|
|
NUCC-390 is a novel and selective small-molecule CXCR4 receptor agonist. NUCC-390 induces internalization of CXCR4 receptors and acts in an opposite way of AMD31...
|
T0801 |
Tannic acid
|
1401-55-4
|
|
|
Tannic acid is a novel hERG channel blocker.
|